Market Insights Consumer OTC Pharmaceuticals

Wound Care - Sweden

Sweden

Revenue in the Wound Care market amounts to €28.84 in 2024. The market is expected to grow annually by 0.66% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€975 in 2024).
In relation to total population figures, per person revenues of €2.70 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Wound Care market in Sweden is experiencing steady growth due to various factors such as an aging population, increasing prevalence of chronic diseases, and advancements in wound care technologies.

Customer preferences: In Sweden, customers prefer wound care products that are effective, easy to use, and promote faster healing. They also value products that are gentle on the skin and have minimal side effects. With a strong focus on sustainability and environmental responsibility, customers in Sweden are increasingly seeking wound care products that are eco-friendly and made from natural materials.

Trends in the market: One of the key trends in the Wound Care market in Sweden is the growing demand for advanced wound care products. As the population ages, the incidence of chronic wounds, such as diabetic ulcers and pressure ulcers, is increasing. This has led to a higher demand for products that can effectively manage and heal these complex wounds. Advanced wound care products, such as dressings with antimicrobial properties and negative pressure wound therapy systems, are gaining popularity in Sweden due to their ability to promote faster healing and reduce the risk of infection. Another trend in the market is the increasing adoption of telemedicine and digital wound management solutions. These technologies allow healthcare professionals to remotely monitor and manage patients' wounds, reducing the need for frequent clinic visits. This is particularly beneficial in Sweden, where access to healthcare services in remote areas can be challenging. Telemedicine and digital wound management solutions not only improve patient convenience but also enable early detection of complications and timely intervention.

Local special circumstances: Sweden has a well-developed healthcare system that provides universal access to high-quality healthcare services. The country has a strong focus on preventive care and health promotion, which includes wound care management. This proactive approach towards healthcare contributes to the growing demand for wound care products in Sweden. Additionally, Sweden has a high life expectancy and an aging population. As people age, the risk of developing chronic wounds increases. This demographic trend is driving the demand for wound care products and services in the country.

Underlying macroeconomic factors: Sweden has a strong and stable economy, which supports the growth of the healthcare sector, including the wound care market. The government invests in healthcare infrastructure and research, creating a favorable environment for the development and adoption of innovative wound care technologies. Furthermore, Sweden has a high level of healthcare expenditure per capita, indicating a willingness to invest in advanced healthcare solutions. This provides opportunities for both domestic and international companies operating in the wound care market. In conclusion, the Wound Care market in Sweden is witnessing growth due to factors such as an aging population, increasing prevalence of chronic diseases, and advancements in wound care technologies. Customer preferences in Sweden include effective and easy-to-use products that promote faster healing. The market is experiencing trends such as the demand for advanced wound care products and the adoption of telemedicine and digital wound management solutions. Sweden's well-developed healthcare system, aging population, and strong economy contribute to the growth of the wound care market in the country.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.